Russia’s first commercial crystalline glyoxal production launched in Siberia
3 Oct '12
Russia’s pioneering commercial crystalline glyoxal production site, based on innovative Tomsk State University technology, has come on-line in Biisk, Altay region, Southern Siberia, news agency RIA Novosti reports.
In an exchange with Alexander Vorozhtsov, director of the Medicine of the Future Platform nonprofit partnering with the project, RIA learned that production has been launched on the premises of the Biisk-based Altay federal R&D and production center. The test run of the new site was conducted in May 2012.
The site will reportedly make 500 tons of crystalline glyoxal a year, using as raw material the glyoxal solution made in another Siberian city, Tomsk.
Biisk-originating glyoxal will have a range of applications in Russia’s military-industrial sector and the pharma industry, the source said. In addition, the project owners are expecting export opportunities; according to Mr. Vorozhtsov, “there’s an order for 20 tons from Italy already.”
Glyoxal has already been known globally for years, and Russia is now reported to be the world’s eighth country to possess technology for its synthesis. Tomsk State University’s own method first tested in the 1990s resulted in 2009 in setting up Russia’s only production of the substance for a variety of uses, including explosives, next gen rocket fuel, medical supplies, and some others—an estimated 2,500 various items.